Fig. 5
From: MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
Chemical structures of small molecule MET inhibitors with their target specificities. IC50, half maximal inhibitory concentration; VEGFR2, vascular endothelial growth factor receptor 2; RET, rearranged during transfection; ALK, anaplastic lymphoma kinase; RON, Recepteur d'Origine Nantais